Pfizer lowers COVID-19 vaccine doses for younger kids in clinical trial
https://healthell.blogspot.com/2021/06/pfizer-lowers-covid-19-vaccine-doses.html
Pfizer lowers COVID-19 vaccine doses for younger kids in clinical trial
Pfizer said it has selected lower dosages of its COVID-19 vaccine for Phase 2/3 portions of its clinical trial involving kids younger than 11 than the volume given to shot recipients ages 12 and older.